August 19th 2025
Altimmune's pemvidutide gains FDA Fast Track designation for alcohol use disorder.
From Psychiatrist to Pioneer: The Reason Why I Opened an Urgent Care for Mental Health
June 16th 2025According to this pioneer, mental health professionals should embrace a new mindset: to consider how to can apply expertise not only within the confines of the exam room, but in boardrooms, in startups, in classrooms, and in community centers.
Read More
In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function
March 27th 2025The prevalence of tobacco use in schizophrenia is over 60%—3 times that of the general population. However, the reason for the high prevalence of tobacco use in schizophrenia remains largely unknown.
Read More
Challenges in Treating Acquired Brain Injury
March 24th 2025Given that individual differences exist regarding the effects of brain injury and gaps persist in the treatment continuum, challenges arise in treating individuals with acquired brain injury. Addressing these challenges can improve patient outcomes.
Read More
Is the Case Settled? Cannabis and Criminal Responsibility
January 13th 2025Understanding the complex relationship between substance use and mental health is critical to providing thorough and well-informed evaluations. Let's take a look at the relationship between cannabis and criminal responsibility.
Read More
Beyond Abstinence: Other Clinically Meaningful Endpoints for Patients With Substance Use Disorders
December 9th 2024While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!
Read More